Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Case of Anomalous Origin of the Middle Cerebral Artery.
Kuczynski AM, Dhall G, Enriquez CAG, Hawkes CM, da Costa L. Kuczynski AM, et al. Among authors: enriquez cag. Can J Neurol Sci. 2025 Jan 8:1-5. doi: 10.1017/cjn.2024.356. Online ahead of print. Can J Neurol Sci. 2025. PMID: 39773543 No abstract available.
CPD Success With Technagogy in Health Professions: Determinants and Merits.
Ong I, Dino MJ, Enriquez CM, Gotinga TJ, Esluzar C, Cajayon S, Buencamino A, Pimentel-Tormon F, Rodriguez A, Tablizo A. Ong I, et al. Among authors: enriquez cm. J Contin Educ Health Prof. 2024 Aug 6. doi: 10.1097/CEH.0000000000000559. Online ahead of print. J Contin Educ Health Prof. 2024. PMID: 39105707
Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer.
Sulsenti R, Scialpi GB, Frossi B, Botti L, Ferri R, Tripodi I, Piva A, Sangaletti S, Pernici D, Cancila V, Romeo F, Chiodoni C, Lecis D, Bianchi F, Fischetti I, Enriquez C, Crivelli F, Bregni M, Renne G, Pece S, Tripodo C, Pucillo CE, Colombo MP, Jachetti E. Sulsenti R, et al. Among authors: enriquez c. Cancer Immunol Res. 2024 Sep 3;12(9):1147-1169. doi: 10.1158/2326-6066.CIR-23-0792. Cancer Immunol Res. 2024. PMID: 38869181 Free PMC article.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell BCV, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 Jun 15;403(10444):2597-2605. doi: 10.1016/S0140-6736(24)00921-8. Epub 2024 May 17. Lancet. 2024. PMID: 38768626 Clinical Trial.
83 results